212 related articles for article (PubMed ID: 32508645)
1. Monoterpenes Differently Regulate Acid-Sensitive and Mechano-Gated K
Arazi E; Blecher G; Zilberberg N
Front Pharmacol; 2020; 11():704. PubMed ID: 32508645
[TBL] [Abstract][Full Text] [Related]
2. Protein and Chemical Determinants of BL-1249 Action and Selectivity for K
Pope L; Arrigoni C; Lou H; Bryant C; Gallardo-Godoy A; Renslo AR; Minor DL
ACS Chem Neurosci; 2018 Dec; 9(12):3153-3165. PubMed ID: 30089357
[TBL] [Abstract][Full Text] [Related]
3. A regulatory domain in the K
Arazi E; Blecher G; Zilberberg N
Mol Cell Neurosci; 2020 Jun; 105():103496. PubMed ID: 32320829
[TBL] [Abstract][Full Text] [Related]
4. Production of K
Lee H; Lolicato M; Arrigoni C; Minor DL
Methods Enzymol; 2021; 653():151-188. PubMed ID: 34099170
[TBL] [Abstract][Full Text] [Related]
5. Temperature sensitivity of two-pore (K2P) potassium channels.
Schneider ER; Anderson EO; Gracheva EO; Bagriantsev SN
Curr Top Membr; 2014; 74():113-33. PubMed ID: 25366235
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of two-pore domain potassium (K2P) channels in cancer.
Williams S; Bateman A; O'Kelly I
PLoS One; 2013; 8(10):e74589. PubMed ID: 24116006
[TBL] [Abstract][Full Text] [Related]
7. Vernakalant activates human cardiac K(2P)17.1 background K(+) channels.
Seyler C; Schweizer PA; Zitron E; Katus HA; Thomas D
Biochem Biophys Res Commun; 2014 Aug; 451(3):415-20. PubMed ID: 25108155
[TBL] [Abstract][Full Text] [Related]
8. Response of the human detrusor to stretch is regulated by TREK-1, a two-pore-domain (K2P) mechano-gated potassium channel.
Lei Q; Pan XQ; Chang S; Malkowicz SB; Guzzo TJ; Malykhina AP
J Physiol; 2014 Jul; 592(14):3013-30. PubMed ID: 24801307
[TBL] [Abstract][Full Text] [Related]
9. K
Lolicato M; Arrigoni C; Mori T; Sekioka Y; Bryant C; Clark KA; Minor DL
Nature; 2017 Jul; 547(7663):364-368. PubMed ID: 28693035
[TBL] [Abstract][Full Text] [Related]
10. Characterization of temperature-sensitive leak K
Viatchenko-Karpinski V; Ling J; Gu JG
Mol Brain; 2018 Jul; 11(1):40. PubMed ID: 29980241
[TBL] [Abstract][Full Text] [Related]
11. Stretch-activated two-pore-domain (K
Schmidt C; Wiedmann F; Kallenberger SM; Ratte A; Schulte JS; Scholz B; Müller FU; Voigt N; Zafeiriou MP; Ehrlich JR; Tochtermann U; Veres G; Ruhparwar A; Karck M; Katus HA; Thomas D
Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):233-243. PubMed ID: 28526353
[TBL] [Abstract][Full Text] [Related]
12. Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein.
Gierten J; Ficker E; Bloehs R; Schlömer K; Kathöfer S; Scholz E; Zitron E; Kiesecker C; Bauer A; Becker R; Katus HA; Karle CA; Thomas D
Br J Pharmacol; 2008 Aug; 154(8):1680-90. PubMed ID: 18516069
[TBL] [Abstract][Full Text] [Related]
13. The Polysite Pharmacology of TREK K
Pope L; Minor DL
Adv Exp Med Biol; 2021; 1349():51-65. PubMed ID: 35138610
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of two-pore domain potassium channels in rat cerebellar granule neurons.
Burgos P; Zúñiga R; Domínguez P; Delgado-López F; Plant LD; Zúñiga L
Biochem Biophys Res Commun; 2014 Oct; 453(4):754-60. PubMed ID: 25305496
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K
Wiedmann F; Schulte JS; Gomes B; Zafeiriou MP; Ratte A; Rathjens F; Fehrmann E; Scholz B; Voigt N; Müller FU; Thomas D; Katus HA; Schmidt C
Basic Res Cardiol; 2018 Jun; 113(4):27. PubMed ID: 29881975
[TBL] [Abstract][Full Text] [Related]
16. Contribution of two-pore K
Chai S; Wan X; Nassal DM; Liu H; Moravec CS; Ramirez-Navarro A; Deschênes I
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1144-H1153. PubMed ID: 28341634
[TBL] [Abstract][Full Text] [Related]
17. New Targets for Old Drugs: Cardiac Glycosides Inhibit Atrial-Specific K
Schmidt C; Wiedmann F; Gaubatz AR; Ratte A; Katus HA; Thomas D
J Pharmacol Exp Ther; 2018 Jun; 365(3):614-623. PubMed ID: 29643254
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cardiac two-pore-domain K+ (K2P) channels by the antiarrhythmic drug vernakalant--comparison with flecainide.
Seyler C; Li J; Schweizer PA; Katus HA; Thomas D
Eur J Pharmacol; 2014 Feb; 724():51-7. PubMed ID: 24374008
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of TREK-TRAAK K
Zhang XT; Xu Z; Shi KP; Guo DL; Li H; Wang L; Zhu XB
Int J Ophthalmol; 2019; 12(6):924-929. PubMed ID: 31236347
[TBL] [Abstract][Full Text] [Related]
20. Two-Pore-Domain Potassium (K
Wiedmann F; Frey N; Schmidt C
Cells; 2021 Oct; 10(11):. PubMed ID: 34831137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
